CD19 and systemic sclerosis: Since patients with SSc express higher levels of CD19 on B-cells and since CD19 is a key molecule in the regulation of signaling thresholds in these cells, something that may relate to break of tolerance and induction of autoimmunity, investigators explored the mechanisms involved in CD19 overexpression in SSc B-cells.